PTEN Hamartoma Tumor Syndrome (PHTS)
Record ID 32010001009
English
Authors' objectives:
PTEN Hamartoma Tumor Syndrome (PHTS) encompasses Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), and Proteus syndrome (PS), which have phenotypic overlap that includes hamartomatous tumors. PHTS has been estimated to affect 1 in 200,000 people worldwide. PHTS is caused by sequence variants in the tumor suppressor phosphatase and tensin homolog (PTEN) gene. PHTS is inherited in an autosomal dominant manner with > 200 pathogenic sequence variants described to date.
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- PTEN Phosphohydrolase
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.